The study also revealed that Trx2 expression reduced hypercholesterolemia-induced atherosclerosis by reducing ROS levels and improving NO bioavailability in Trx2 TG/ApoE−/− mice, resulting in significantly reduced lesions compared to ApoE−/− mice [232]. Here, APOE is linked to Hypercholesterolemia.